At MD Anderson, he directs a research laboratory focused on drug resistance and mechanisms of pathogenesis in osteosarcoma. He is active in clinical trials and care for patients with bone sarcomas.

Dr. Gorlick is the Past Chair of the Bone Tumor Disease Committee of the
Children’s Oncology Group (COG), the international research organization devoted to optimizing the cure of childhood cancer through scientific discovery.